Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Oxycyte"'
Publikováno v:
Undersea and Hyperbaric Medicine. 48:25-31
Background: The treatment of decompression sickness (DCS) with hyperbaric oxygen (HBO2) serves to decrease intravascular bubble size, increase oxygen (O2) delivery to tissue and enhance the elimination of inert gas. Emulsified perfluorocarbons (PFC)
Autor:
Josie C van Kralingen, Keith W. Muir, I. Mhairi Macrae, Lorraine M. Work, Graeme A. Deuchar, Celestine Santosh, Christopher McCabe
Publikováno v:
Translational Stroke Research
In acute stroke patients, penumbral tissue is non-functioning but potentially salvageable within a time window of variable duration and represents target tissue for rescue. Reperfusion by thrombolysis and/or thrombectomy can rescue penumbra and impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520241d79d37db6d34377b88cf27ecd2
https://eprints.gla.ac.uk/173463/1/173463.pdf
https://eprints.gla.ac.uk/173463/1/173463.pdf
Autor:
Richard M. McCarron, Ashraful Haque, Charles R. Auker, Francoise Arnaud, Anke H. Scultetus, Richard T. Mahon, George McNamee, Leonora J. Dickson, Steve J. Chun
Publikováno v:
Lung. 194:945-957
Perfluorocarbons (PFCs) can transport 50 times more oxygen than human plasma. Their properties may be advantageous in preservation of tissue viability in oxygen-deprived states, such as in acute lung injury. We hypothesized that an intravenous dose o
Autor:
David P. Regis, Charles R. Auker, Angela L. Senese, Richard T. Mahon, Francoise Arnaud, William A. Cronin
Publikováno v:
Blood Coagulation & Fibrinolysis. 27:702-710
Decompression from elevated ambient pressure is associated with platelet activation and decreased platelet counts. Standard treatment for decompression sickness (DCS) is hyperbaric oxygen therapy. Intravenous perfluorocarbon (PFC) emulsion is a nonre
Publikováno v:
Talanta. 144:196-203
A headspace-gas chromatography-tandem mass spectrometry (HS-GC-MS/MS) method for the trace measurement of perfluorocarbon compounds (PFCs) in blood was developed. Due to oxygen carrying capabilities of PFCs, application to doping and sports misuse is
Autor:
Richard T. Mahon, Shravalya Tirumala, Michael Bodo, David P. Regis, William A. Cronin, Charles R. Auker
Publikováno v:
Journal of Applied Physiology. 118:71-79
Intravenous perfluorocarbons (PFC) have reduced the effects of decompression sickness (DCS) and improved mortality rates in animal models. However, concerns for the physiological effects of DCS combined with PFC therapy have not been examined in a ba
Autor:
Paula F. Moon-Massat, Chioma Aligbe, Biswajit K. Saha, Saad H. Mullah, Lam Thuy Vi Tran Ho, Georgina Pappas, Rania Abutarboush, Ashraful Haque, Charles R. Auker, Richard M. McCarron, Francoise Arnaud, Peter B. Walker, Anke H. Scultetus
Publikováno v:
Microcirculation (New York, N.Y. : 1994). 25(3)
OBJECTIVE The aim of this study was to assess, in two experiments, the safety and efficacy of the PFC emulsion Oxycyte as an oxygen therapeutic for TBI to test the hypothesis that early administration of this oxygen-carrying fluid post-TBI would impr
Publikováno v:
Metabolic Brain Disease. 30:473-482
A need exists for the effective treatment of individuals suffering from spinal cord injury (SCI). Recent advances in the understanding of the pathophysiological mechanisms occurring in SCI have resulted in an expansion of new therapeutic targets. Thi
Publikováno v:
Journal of Surgical Research. 187:324-333
Background Arterial gas embolism (AGE) is a clinical problem that occurs directly in cardiopulmonary bypass machines in open-heart surgeries, or indirectly (through cardiac or pulmonary right to left shunts) in dive accidents, resulting in serious mo
Publikováno v:
European Journal of Applied Physiology. 113:2795-2802
Standard treatment for decompression sickness (DCS) is recompression therapy with hyperbaric oxygen (HBO). Non-recompressive therapies are needed to address mass casualty scenarios such as a disabled submarine rescue or DCS therapy in remote environm